Literature DB >> 1407246

Parkinson's disease in Taiwan: an analysis of 215 patients.

L G Chia1, L H Liu.   

Abstract

215 Chinese Parkinson's disease (PD) patients on levodopa therapy were followed up between 1982 and 1991. The ratio of males to females was 2.4 to 1. The mean durations from onset of the illness to stages I and II of Hoehn and Yahr (mild disability) were 4.0 and 6.5 years, to stage III (moderate) 7.9 years, and to stages IV and V (severe) 9.8 and 11.8 years. The mean duration of illness for living patients was 8.6 years. The mean duration of illness before death for the 46 patients who died was 8.9 years. The mean age at death was 68 years (4.4 years less than the normal life expectancy in Taiwan). The fate of this disease showed that patients with unilateral symptoms initially had a better prognosis than those with bilateral symptoms. The symptoms at onset were unilateral in 70% of the patients, of whom 91% had a spread of symptoms to the opposite side after a mean of 3.4 years. Familial PD occurred in 2.8% of our patients. The occurrence of blood ABO groups was not significantly different between the PD patients and the general population of Taiwan. Our findings differed from those in Western series by having a predominance of males, and a relatively shorter duration of unilateral symptoms before spread to the opposite side. In addition, the duration of illness and the survival time under levodopa treatment were shorter in Taiwanese and Japanese than in Western series.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407246     DOI: 10.1159/000110920

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  4 in total

Review 1.  A systematic review of loss of independence in Parkinson's disease.

Authors:  Angus D Macleod; J W Kerr Grieve; Carl E Counsell
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

2.  Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia.

Authors:  M Atadzhanov; A Zumla; P Mwaba
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

3.  ABO blood group and neurodegenerative disorders: more than a casual association.

Authors:  Massimo Franchini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-11-23       Impact factor: 3.443

Review 4.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.